Jes Ú S Guinea - Infectious Diseases

Author Information

Jesús Guinea is a distinguished researcher affiliated with the Clinical Microbiology and Infectious Diseases department at Hospital General Universitario Gregorio Marañón in Madrid, Spain. His work primarily focuses on infectious diseases, with a strong emphasis on the study of fungal infections and the impact of COVID-19.

Research Contributions

Jesús Guinea has made significant contributions to the field of infectious diseases, with a primary focus on fungal infections and the implications of COVID-19. His recent research has explored topics such as post-COVID-19 syndrome and the performance of SARS-CoV-2 antigen detection devices. Additionally, he has investigated the incidence of candidemia in COVID-19 patients, the antifungal susceptibility of dermatophytes, and the spread of fluconazole-resistant Candida parapsilosis in Spain. His work is crucial for understanding and managing infectious diseases, particularly in the context of the ongoing pandemic.

Aliases

Jesús Guinea is known by several aliases, including Jes Ú S Guinea, J Guinea, Jesus Guinea, J. Guinea, and Jesús Guinea. These variations may appear in different publications or databases.

Publication and Citation Metrics

Metric	Value
Citation Count	10,141
H-index	46
Paper Count	258

Publications:

Post-COVID-19 syndrome. SARS-CoV-2 RNA detection in plasma, stool, and urine in patients with persistent symptoms after COVID-19

DOI: 10.1186/s12879-022-07153-4

Year: 2022

Different performance of three point-of-care SARS-CoV-2 antigen detection devices in symptomatic patients and close asymptomatic contacts: a real-life study

DOI: 10.1016/j.cmi.2022.02.014

Year: 2022

ΔF659 and F659S substitutions at the HS1 of FKS2 gene, along with E655A and W715L upstream and downstream substitutions, correlate with high ibrexafungerp MICs against Candida glabrata.

DOI: 10.1016/j.cmi.2022.04.003

Year: 2022

Incidence of Candidemia Is Higher in COVID-19 versus Non-COVID-19 Patients, but Not Driven by Intrahospital Transmission

DOI: 10.3390/jof8030305

Year: 2022

Comment on: Multicentre validation of a EUCAST method for the antifungal susceptibility testing of microconidia-forming dermatophytes.

DOI: 10.1093/jac/dkac004

Year: 2022

Air pollution and health prevention: A document of reflection.

DOI: 10.37201/req/171.2021

Year: 2022

Fluconazole-resistant Candida parapsilosis clonally related genotypes: first report proving the presence of endemic isolates harbouring the Y132F ERG11 gene substitution in Spain.

DOI: 10.1016/j.cmi.2022.02.025

Year: 2022

High incidence of COVID-19 at nursing homes in Madrid, Spain, despite preventive measures.

DOI: 10.37201/req/008.2022

Year: 2022

Evaluation of the VITEK MS system for the identification of filamentous fungi.

DOI: 10.1093/mmy/myac027

Year: 2022

Spectrophotometric azole and amphotericin B MIC readings against Aspergillus fumigatus sensu lato using the EUCAST 9.3.2 methodology. Are ≥ 90% and ≥ 95% fungal growth inhibition endpoints equally suitable?

DOI: 10.1093/mmy/myab072

Year: 2021

How Does Genomic Sequencing Aid in Disease Surveillance?

How to Interpret Chest CT Scan Results?

How is Rabies Transmitted?

What are the Symptoms in Humans?

What Role Do Vaccines Play in Preventing Airborne Diseases?

When are Quarantine and Isolation Used?

What are MHC Genes?

What Are the Challenges in Targeting Fatty Acid Biosynthesis?

What Are Respiratory Droplets?

How Does the CDC Respond to Emerging Infectious Diseases?

Partnered Content Networks

Relevant Topics